Inventor · disambiguated record
Gary K. Schwartz
Also filed as: SCHWARTZ GARY · SCHWARTZ GARY G · SCHWARTZ GARY K
9 granted patents·4 pending applications·100 citations·filing 1996–2022
84Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER6SLOAN KETTERING INST CANCER4MEDICINOVA INC1REGENERON PHARMA1
Top patents by PatentIndex Score
13 records- 0182US5821072ACombinations of PKC inhibitors and therapaeutic agents for treating cancersSLOAN KETTERING INST CANCER·Filed 1996·Granted Oct 13, 1998·69 cites·3 claims
- 0281US9889135B2Companion diagnostic for CDK4 inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Feb 13, 2018·7 cites·10 claims
- 0377US10858655B2Methods and compositions for treating cancer using peptide nucleic acid-based agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Dec 8, 2020·1 cites·5 claims
- 0467US11518996B2Methods and compositions for treating cancer using peptide nucleic acid-based agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Granted Dec 6, 2022·0 cites·20 claims
- 0564US6444638B2Combinations of PKC inhibitors and therapeutic agents for treating cancersSLOAN KETTERING INST CANCER·Filed 1998·Granted Sep 3, 2002·23 cites·21 claims
- 0660US12005049B2Methods of preventing cancer metastasisMEDICINOVA INC·Filed 2022·Granted Jun 11, 2024·0 cites·16 claims
- 0758US10113169B2Methods and compositions for treating cancer using peptide nucleic acid-based agentsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2014·Granted Oct 30, 2018·0 cites·13 claims
- 0857US7045495B2Combination of bryostatin and paclitaxel for treating cancerSLOAN KETTERING INST CANCER·Filed 2002·Granted May 16, 2006·0 cites·5 claims
- 0952US2019376149A1Ddx43 as a biomarker of resistance to mek1/2 inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 1050US2004087559A1Methods for prevention and treatment of cancerFiled 2003·Application pending·0 cites
- 1149US2022040319A1Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind metREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1247US10400285B2DDX43 as a biomarker of resistance to MEK1/2 inhibitorsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Sep 3, 2019·0 cites·6 claims
- 1344US2004219508A1Screening, quantitation and identification of active ingredients in natural productsSLOAN KETTERING INST CANCER·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gary K. Schwartz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →